Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 36 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

28%

10 trials in Phase 3/4

Results Transparency

6%

1 of 18 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

27Total
Not Applicable (13)
Early P 1 (1)
P 1 (2)
P 2 (1)
P 3 (3)
P 4 (7)

Trial Status

Completed18
Unknown11
Not Yet Recruiting5
Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (36)

Showing 20 of 20 trials
NCT07566650Not ApplicableNot Yet RecruitingPrimary

High-Intensity Transcranial Alternating Current Stimulation (Hi-tACS) for Hypertension: A Randomized Controlled Trial

NCT07272486Not ApplicableCompleted

The Use of Virtual Reality and Music Therapy for Hypertensive Urgency

NCT07486453Phase 1Not Yet RecruitingPrimary

Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets

NCT06884085Phase 1CompletedPrimary

A Study to Compare to PK Characteristics and Safety Profiles Between AD-227 and Co-administration of AD-227A and AD-227B

NCT07236125Not Yet RecruitingPrimary

Dietary Nitrate and the Oral Microbiome in Children With Primary Hypertension

NCT07192783Not ApplicableRecruitingPrimary

The Effect of Lavender Inhalation on Anxiety, Sleep, and Blood Pressure

NCT06929728Not Yet RecruitingPrimary

Automatic and Conventional Methods of Hypertensive Patients Monitoring

NCT03310684Completed

Pediatric Primary Hypertension and the Renin-Angiotensin System (PHRAS)

NCT05683301Phase 4CompletedPrimary

Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India

NCT06049862Not ApplicableCompletedPrimary

The Effectiveness of "MaRiTensi" in Increasing Self-Care and Blood Pressure Control: Randomized Controlled Trial

NCT04788563Not ApplicableCompletedPrimary

A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community

NCT05917275Phase 4RecruitingPrimary

Multi-Omics to Predict the Blood Pressure Response to Antihypertensives

NCT06208072Not ApplicableUnknownPrimary

The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.

NCT06116357Not ApplicableNot Yet RecruitingPrimary

The Safety and Efficacy of Carotid Body Modulation Therapy in Hypertensive Patients by External Ultrasonic Micro-bubble

NCT06091176Not ApplicableUnknown

Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension

NCT01742702UnknownPrimary

HaemoDYNAMICs in Primary and Secondary Hypertension

NCT03015311Not ApplicableUnknownPrimary

Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients

NCT04381520Not ApplicableUnknownPrimary

Heat-sensitive Moxibustion Self-administration in Patients in the Community With Primary Hypertension: Protocol for a Multi-center, Pragmatic, Non-randomized Trial

NCT02194465Phase 2CompletedPrimary

A Study of LY2623091 in Participants With High Blood Pressure

NCT03491813UnknownPrimary

Comparisonbetween Primary Hypertension Monitoring Methods for Detection of Early Kidney Dysfunction

Scroll to load more

Research Network

Activity Timeline